Oxylipins produced by Pseudomonas aeruginosa promote biofilm formation and virulence

The oxygenation of unsaturated fatty acids by dioxygenases occurs in all kingdoms of life and produces physiologically important lipids called oxylipins. The biological roles of oxylipins have been extensively studied in animals, plants, algae and fungi, but remain largely unidentified in prokaryote...

Full description

Saved in:
Bibliographic Details
Published inNature communications Vol. 7; no. 1; pp. 13823 - 10
Main Authors Martínez, Eriel, Campos-Gómez, Javier
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 08.12.2016
Nature Publishing Group
Nature Portfolio
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The oxygenation of unsaturated fatty acids by dioxygenases occurs in all kingdoms of life and produces physiologically important lipids called oxylipins. The biological roles of oxylipins have been extensively studied in animals, plants, algae and fungi, but remain largely unidentified in prokaryotes. The bacterium Pseudomonas aeruginosa displays a diol synthase activity that transforms several monounsaturated fatty acids into mono- and di-hydroxylated derivatives. Here we show that oxylipins derived from this activity inhibit flagellum-driven motility and upregulate type IV pilus-dependent twitching motility of P. aeruginosa. Consequently, these oxylipins promote bacterial organization in microcolonies, increasing the ability of P. aeruginosa to form biofilms in vitro and in vivo (in Drosophila flies). We also demonstrate that oxylipins produced by P. aeruginosa promote virulence in Drosophila flies and lettuce. Our study thus uncovers a role for prokaryotic oxylipins in the physiology and pathogenicity of bacteria. Oxygenated fatty acids known as oxylipins play important roles in mammals, plants and fungi. Here, the authors show that oxylipins, produced by the pathogenic bacterium Pseudomonas aeruginosa , promote biofilm formation and virulence.
ISSN:2041-1723
2041-1723
DOI:10.1038/ncomms13823